MX2017014463A - Cabazitaxel y su uso para tratar cancer. - Google Patents
Cabazitaxel y su uso para tratar cancer.Info
- Publication number
- MX2017014463A MX2017014463A MX2017014463A MX2017014463A MX2017014463A MX 2017014463 A MX2017014463 A MX 2017014463A MX 2017014463 A MX2017014463 A MX 2017014463A MX 2017014463 A MX2017014463 A MX 2017014463A MX 2017014463 A MX2017014463 A MX 2017014463A
- Authority
- MX
- Mexico
- Prior art keywords
- cabazitaxel
- treating cancer
- cancer
- solvate
- hydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Abstract
La presente invención se refiere al compuesto que tiene la fórmula (I): (ver Fórmula) que puede estar en forma de base o en la forma de un hidrato o un solvato, para su uso como un medicamento en el tratamiento de cáncer en pacientes con insuficiencia hepática.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15305720.3A EP3093014A1 (en) | 2015-05-13 | 2015-05-13 | Cabazitaxel and its use for treating cancer |
PCT/EP2016/060759 WO2016180943A1 (en) | 2015-05-13 | 2016-05-12 | Cabazitaxel and its use for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017014463A true MX2017014463A (es) | 2018-03-21 |
Family
ID=53177311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017014463A MX2017014463A (es) | 2015-05-13 | 2016-05-12 | Cabazitaxel y su uso para tratar cancer. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20160331717A1 (es) |
EP (3) | EP3093014A1 (es) |
JP (1) | JP2018516890A (es) |
KR (1) | KR20180006417A (es) |
CN (1) | CN108135878A (es) |
AU (1) | AU2016259775A1 (es) |
CA (1) | CA2985408A1 (es) |
EA (1) | EA201792502A1 (es) |
ES (1) | ES2774101T3 (es) |
IL (1) | IL255541A (es) |
MX (1) | MX2017014463A (es) |
PL (1) | PL3294285T3 (es) |
PT (1) | PT3294285T (es) |
TW (1) | TW201705950A (es) |
WO (1) | WO2016180943A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3093014A1 (en) | 2015-05-13 | 2016-11-16 | Aventis Pharma S.A. | Cabazitaxel and its use for treating cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA23823A1 (fr) | 1995-03-27 | 1996-10-01 | Aventis Pharma Sa | Nouveaux taxoides, leur preparation et les compositions qui les contiennent |
US5847170A (en) | 1995-03-27 | 1998-12-08 | Rhone-Poulenc Rorer, S.A. | Taxoids, their preparation and pharmaceutical compositions containing them |
ATE302685T1 (de) | 2003-07-02 | 2005-09-15 | Scheuten Glasgroep Bv | Verfahren zur herstellung einer brandschutzverglasung |
FR2859996B1 (fr) * | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
PE20121429A1 (es) * | 2009-10-29 | 2012-11-06 | Aventis Pharma Sa | Nuevo uso antitumoral de cabazitaxel |
EA201200617A1 (ru) * | 2009-11-23 | 2012-11-30 | Серулин Фарма Инк. | Полимеры на основе циклодекстрина для доставки лекарственных средств |
KR20140062485A (ko) * | 2011-09-15 | 2014-05-23 | 노파르티스 아게 | 중등도 간 손상 환자의 암 치료에 있어서 4-아미노-5-플루오로-3-[6-(4-메틸피페라진-1-일)-1h-벤즈이미다졸-2-일]-1h-퀴놀린-2-온의 용도 |
EP3093014A1 (en) | 2015-05-13 | 2016-11-16 | Aventis Pharma S.A. | Cabazitaxel and its use for treating cancer |
-
2015
- 2015-05-13 EP EP15305720.3A patent/EP3093014A1/en not_active Ceased
-
2016
- 2016-05-12 PL PL16721844T patent/PL3294285T3/pl unknown
- 2016-05-12 KR KR1020177035580A patent/KR20180006417A/ko unknown
- 2016-05-12 CN CN201680040986.2A patent/CN108135878A/zh active Pending
- 2016-05-12 JP JP2017558939A patent/JP2018516890A/ja active Pending
- 2016-05-12 ES ES16721844T patent/ES2774101T3/es active Active
- 2016-05-12 AU AU2016259775A patent/AU2016259775A1/en not_active Abandoned
- 2016-05-12 EP EP16721844.5A patent/EP3294285B1/en not_active Revoked
- 2016-05-12 CA CA2985408A patent/CA2985408A1/en not_active Abandoned
- 2016-05-12 EP EP19209255.9A patent/EP3643307A1/en not_active Withdrawn
- 2016-05-12 EA EA201792502A patent/EA201792502A1/ru unknown
- 2016-05-12 PT PT167218445T patent/PT3294285T/pt unknown
- 2016-05-12 MX MX2017014463A patent/MX2017014463A/es unknown
- 2016-05-12 WO PCT/EP2016/060759 patent/WO2016180943A1/en active Application Filing
- 2016-05-12 US US15/153,128 patent/US20160331717A1/en not_active Abandoned
- 2016-05-13 TW TW105114982A patent/TW201705950A/zh unknown
-
2017
- 2017-11-09 IL IL255541A patent/IL255541A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2018516890A (ja) | 2018-06-28 |
EP3294285A1 (en) | 2018-03-21 |
ES2774101T3 (es) | 2020-07-16 |
CN108135878A (zh) | 2018-06-08 |
CA2985408A1 (en) | 2016-11-17 |
IL255541A (en) | 2018-01-31 |
US20160331717A1 (en) | 2016-11-17 |
WO2016180943A1 (en) | 2016-11-17 |
EP3643307A1 (en) | 2020-04-29 |
TW201705950A (zh) | 2017-02-16 |
AU2016259775A1 (en) | 2018-01-04 |
EP3093014A1 (en) | 2016-11-16 |
PT3294285T (pt) | 2020-03-06 |
EP3294285B1 (en) | 2019-12-18 |
KR20180006417A (ko) | 2018-01-17 |
EA201792502A1 (ru) | 2018-02-28 |
PL3294285T3 (pl) | 2020-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501084A1 (en) | Heterocyclic compounds as immunomodulators | |
MX2021006531A (es) | Composicion que contiene arn para tratamiento de enfermedades tumorales. | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
MX2020012165A (es) | Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer. | |
IN2015DN01156A (es) | ||
MX2016002544A (es) | Compuestos utiles como inmunomoduladores. | |
MD20170016A2 (ro) | Compuşi aminopirimidinici ca inhibitori JAK | |
MY198613A (en) | Nitrobenzyl derivatives of anti-cancer agents | |
PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
PH12016500270A1 (en) | Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases | |
MX2016015434A (es) | Combinaciones farmaceuticas para tratar cancer. | |
BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
PH12016502352A1 (en) | Pharmaceutical composition | |
MX2019013808A (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer. | |
CA2908742C (en) | Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer | |
EP3212658A4 (en) | 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer | |
PH12016502353A1 (en) | Pharmaceutical composition | |
MX2017000312A (es) | Derivados de isoindolina para usarse en el tratamiento de una infeccion viral. | |
MX2016015378A (es) | Uso de eribulina en el tratamiento de cancer. | |
MX2017013360A (es) | Métodos para tratar el cáncer. | |
MX2018006953A (es) | Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer. | |
MY186475A (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
MX2017009608A (es) | Compuestos anticancerigenos. | |
MX2017002544A (es) | Derivados de isoquinolinona utiles en el tratamiento contra el cancer. |